Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors

Published:2023-04 Issue: Volume:184 Page:103929
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Ferrara Miriam Grazia,Belluomini Lorenzo,Smimmo Annafrancesca,Sposito Marco,Avancini Alice,Giannarelli Diana,Milella Michele,Pilotto Sara,Bria Emilio

Funder

Airc Italian Foundation for Cancer Research

Ministero della Salute

Associazione Italiana per la Ricerca sul Cancro

Università Cattolica del Sacro Cuore

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference47 articles.

1. Influence of TP53 mutation on survival in patients with advanced EGFR-mutant non-small-cell lung cancer;Aggarwal;JCO Precis Oncol.,2018

2. Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface;Belluomini;ESMO Open,2021

3. Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers;Blakely;Nat. Genet.,2017

4. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer;Bremnes;J. Clin. Oncol.,2002

5. Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma;Bria;Oncotarget,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17);ESMO Open;2024-09

2. Successful EGFR Mutation Detection in Cytological Specimens of Lung Cancer with Challenging Biopsies by Integrating Virtual Bronchoscopy Navigation and Endobronchial Ultrasound Guidance with Highly Sensitive Next-Generation Sequencing: A Case Report;Case Reports in Oncology;2024-08-05

3. Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study;Frontiers in Oncology;2024-07-09

4. Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104);Cell Reports Medicine;2024-07

5. Current status of molecular diagnostics for lung cancer;Exploration of Targeted Anti-tumor Therapy;2024-06-27